Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rybak

Showing results (121-130 of 531) with videos related to

Pageof 54
Sort By:
Antimicrobial Agents and Chemotherapy|September 10, 2009
In vitro activity of ceftaroline against methicillin-resistant Staphylococcus aureus and heterogeneous vancomycin-intermediate S. aureus in a hollow fiber modelCéline Vidaillac, Steve N Leonard, Michael J Rybak
Pharmacotherapy|February 2, 2023
Oral stepdown in Gram-positive bloodstream infections: A step in the right directionKaylee E Caniff, Nicholas Rebold, Michael J Rybak
Pharmacotherapy|September 6, 2019
Parenteral Fosfomycin for the Treatment of Multidrug Resistant Bacterial Infections: The Rise of the EpoxideTrang D Trinh, Jordan R Smith, Michael J Rybak
Antimicrobial Agents and Chemotherapy|July 2, 2008
Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetationsWarren E Rose, Steven N Leonard, Michael J Rybak
Pharmacotherapy|February 24, 2001
Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactamT K Jellison, P S Mckinnon, M J Rybak
Antimicrobial Agents and Chemotherapy|June 1, 1992
Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplaninM J Rybak, E M Bailey, L H Warbasse
Antimicrobial Agents and Chemotherapy|August 1, 1991
Clinical evaluation of teicoplanin fluorescence polarization immunoassayM J Rybak, E M Bailey, V N Reddy
The Annals of Pharmacotherapy|October 1, 1993
Enterococcus, an emerging pathogenS A Tailor, E M Bailey, M J Rybak
Antimicrobial Agents and Chemotherapy|June 1, 1997
Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faeciumR C Mercier, H H Houlihan, M J Rybak
Pharmacotherapy|January 10, 2019
The Optimal Use of the Polymyxins Before Their Time Is UpSara Alosaimy, Sarah C J Jorgensen, Michael J Rybak
Pageof 54

Showing results (121-130 of 531) with videos related to

Sort By:
Pageof 54
Antimicrobial Agents and Chemotherapy|September 10, 2009
In vitro activity of ceftaroline against methicillin-resistant Staphylococcus aureus and heterogeneous vancomycin-intermediate S. aureus in a hollow fiber modelCéline Vidaillac, Steve N Leonard, Michael J Rybak
Pharmacotherapy|February 2, 2023
Oral stepdown in Gram-positive bloodstream infections: A step in the right directionKaylee E Caniff, Nicholas Rebold, Michael J Rybak
Pharmacotherapy|September 6, 2019
Parenteral Fosfomycin for the Treatment of Multidrug Resistant Bacterial Infections: The Rise of the EpoxideTrang D Trinh, Jordan R Smith, Michael J Rybak
Antimicrobial Agents and Chemotherapy|July 2, 2008
Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetationsWarren E Rose, Steven N Leonard, Michael J Rybak
Pharmacotherapy|February 24, 2001
Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactamT K Jellison, P S Mckinnon, M J Rybak
Antimicrobial Agents and Chemotherapy|June 1, 1992
Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplaninM J Rybak, E M Bailey, L H Warbasse
Antimicrobial Agents and Chemotherapy|August 1, 1991
Clinical evaluation of teicoplanin fluorescence polarization immunoassayM J Rybak, E M Bailey, V N Reddy
The Annals of Pharmacotherapy|October 1, 1993
Enterococcus, an emerging pathogenS A Tailor, E M Bailey, M J Rybak
Antimicrobial Agents and Chemotherapy|June 1, 1997
Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faeciumR C Mercier, H H Houlihan, M J Rybak
Pharmacotherapy|January 10, 2019
The Optimal Use of the Polymyxins Before Their Time Is UpSara Alosaimy, Sarah C J Jorgensen, Michael J Rybak
Pageof 54